1.800.KIDS DOC | 1.800.543.7362

Arie S. Friedman, MD

Arie S. Friedman, MD

Member, Children's Community Physicians Association

Clinical Instructor of Pediatrics (Community Based Primary Care), Northwestern University Feinberg School of Medicine

Specialties, Programs & Conditions

Specialties:

Primary Care Pediatrics

Education & Training

Education: University of Illinois College of Medicine at Chicago, 1998,

Postgraduate Training: Residency in pediatrics, University of Chicago Comer Children's Hospital, 1998-2001

Board Certifications: General Pediatrics

Publications

Most recent publications

Open-label use of highly purified CBD (Epidiolex(R)) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes Epilepsy Behav86131-137
The incidence and significance of periictal apnea in epileptic seizures Epilepsia59 (3): 573-582
Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder Am J Med Genet A170 (7): 1791-8
Pediatric acute scrotal pain: A guide to patient assessment and triage J Pediatr Urol12 (2): 72-5
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial Lancet Neurol15 (3): 270-8
Inhospital and Post-discharge Changes in Renal Function After Transcatheter Aortic Valve Replacement Am J Cardiol117 (4): 633-9
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study Neuro Oncol16 (2): 310-7
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): A Pediatric Brain Tumor Consortium Study (PBTC-022) Cancer119 (23): 4180-7
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study Neuro Oncol14 (11): 1404-12
Phenotypic heterogeneity of genomic disorders and rare copy-number variants N Engl J Med367 (14): 1321-31

Call for Insurance information: 1.800.543.7362